These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17257084)

  • 21. Comparison of treatment results between selective peripheral denervation and deep brain stimulation in patients with cervical dystonia.
    Huh R; Han IB; Chung M; Chung S
    Stereotact Funct Neurosurg; 2010; 88(4):234-8. PubMed ID: 20460953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
    Ford B; Louis ED; Greene P; Fahn S
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic.
    Cohen-Gadol AA; Ahlskog JE; Matsumoto JY; Swenson MA; McClelland RL; Davis DH
    J Neurosurg; 2003 Jun; 98(6):1247-54. PubMed ID: 12816272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective peripheral denervation for spasmodic torticollis: is the outcome predictable?
    Braun V; Richter HP; Schröder JM
    J Neurol; 1995 Aug; 242(8):504-7. PubMed ID: 8530977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment strategies for dystonia.
    Cloud LJ; Jinnah HA
    Expert Opin Pharmacother; 2010 Jan; 11(1):5-15. PubMed ID: 20001425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of spasmodic torticollis by local injections of botulinum toxin].
    Jedynak CP; de Saint Victor JF
    Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The phenomenology of cervical dystonia].
    Reichel G; Stenner A; Jahn A
    Fortschr Neurol Psychiatr; 2009 May; 77(5):272-7. PubMed ID: 19418385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
    Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
    Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years.
    Walsh RA; Sidiropoulos C; Lozano AM; Hodaie M; Poon YY; Fallis M; Moro E
    Brain; 2013 Mar; 136(Pt 3):761-9. PubMed ID: 23423670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients.
    Braun V; Richter HP
    J Neurosurg; 2002 Sep; 97(2 Suppl):207-12. PubMed ID: 12296680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [First experiences in deep brain stimulation for cervical dystonia].
    Bötzel K; Steude U
    Nervenarzt; 2006 Aug; 77(8):940-5. PubMed ID: 16858615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
    Brefel-Courbon C; Simonetta-Moreau M; Moré C; Rascol O; Clanet M; Montastruc JL; Lapeyre-Mestre M
    Clin Neuropharmacol; 2000; 23(4):203-7. PubMed ID: 11020124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy.
    Krauss JK; Loher TJ; Pohle T; Weber S; Taub E; Bärlocher CB; Burgunder JM
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):249-56. PubMed ID: 11796777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and Idiopathic Cervical Dystonia in Two Family Members: A Challenging Diagnosis.
    Antelmi E; Conti E; Carecchio M; Tinazzi M
    Tremor Other Hyperkinet Mov (N Y); 2020 Dec; 10():51. PubMed ID: 33354397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of selective peripheral denervation in combination with pallidal deep brain stimulation for the treatment of cervical dystonia.
    Chung M; Han I; Chung SS; Jang DK; Huh R
    Acta Neurochir (Wien); 2015 Mar; 157(3):435-42. PubMed ID: 25471274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective peripheral denervation for the treatment of spasmodic torticollis.
    Braun V; Richter HP
    Neurosurgery; 1994 Jul; 35(1):58-62; discussion 62-3. PubMed ID: 7936153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin Treatment of Cervical Dystonia.
    Bledsoe IO; Comella CL
    Semin Neurol; 2016 Feb; 36(1):47-53. PubMed ID: 26866496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin therapy of dystonia.
    Dressler D; Adib Saberi F; Rosales RL
    J Neural Transm (Vienna); 2021 Apr; 128(4):531-537. PubMed ID: 33125571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.